Radiolabeled Study of CC-220 in Healthy Male Subjects
NCT03294603
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteer
Interventions
DRUG:
CC-220
RADIATION:
[14C]
Sponsor
Celgene